Reproduction 4 - STIs Flashcards
List high risk groups
o Young people
o Minority ethnic groups
o Those affected by poverty and social exclusion
o Low socio-economic status groups
o Those with poor educational opportunities
o Unemployed people
o Individuals born to teenage mothers
What data sources are there for information on STIs etc?
o Genitourinary Medicine (GUM) Clinics
▪ Open access clinics that offer free, confidential sexual health services including diagnosis and treatment of STIs.
▪ Data from GUM clinics is underestimated, as many patients present via other settings, e.g. GP
o Communicable disease surveillance centres
▪ Notified of aggregate data via regular returns from GUM clinics and receive data on gonorrhoea, genital chlamydia, genital herpes and syphilis through voluntary or statutory reporting.
What morbidities are STIs associated with?
o Pelvic Inflammatory Disease (PID)
o Impaired fertility
o Reproductive tract cancers
o Risk of infection with blood-borne viruses – HBV, HIV
o Risk of congenital or peripartum infection of neonate
Identify the infecting organism for genital warts and what kind of virus is it?
Human Papillomaviruses - Small double stranded DNA virus
Describe the organism responsible for genital herpes
Herpes Simplex Virus is an encapsulated, double stranded DNA virus.
Genitial herpes usually associated with HSV2 (HSV usually cold sores)
Organism responsible for chlamydia
Chlamydia Trachomatis: Gram –‘ve obligate intracellular bacterium.
Organism causing gonorrhoea
Neisseria Gonorrhoeae: Gram –‘ve intracellular diplococcus.
Organism for syphilis
Treponema Pallidum - spirochaete - dark field microscopy
Differential diagnosis for genital skin and membrane lesions
o Genital ulcers
o Vesicles or bullae
o Genital papules
o Anogenital warts
Differential diagnosis for urethritis
o Gonococcal urethritis o Chlamydial urethritis o Non-specific urethritis o Post-gonococcal urethritis o Non-infectious urethritis
Differential diagnosis for vulvo-vaginitis & cervicitis
o Vulvo-vaginitis
o Cervicitis
o Bacterial vaginosis
o Bartholinitis
Infections of the female pelvis
o Pregnancy-related
o Pelvic Inflammatory Disease (PID)
Discuss recent trends in the incidence of STIs
OVERALL INCREASE
• Increased transmission
– changing sexual and social behaviour
– increasing density and mobility of populations
• Increased GUM attendance
• Greater public, medical and national
awareness (e.g. with campaigns)
• Improved diagnostic methods including screening programs
Presentation, diagnosis and treatment of chlamydia
Clinical Presentation in Males
o Urethritis, epididymitis, prostatitis, proctitis
Clinical Presentation in Females
o Urethritis, cervicitis, salpingitis, perihepatitis
Diagnosis
o Endocervical and urethral swabs
Treatment
o Doxycycline or Azithromycin
Presentation, diagnosis and management of gonorrhoea
Clinical Presentation in Males
o Urethritis, epididymitis, prostatitis, proctitis, pharyngitis
Clinical Presentation in Females
o Asymptomatic, endocervicitis, urethritis, PID
Disseminated Gonococcal infection
o Bacteraemia, skin and joint lesions
Diagnosis: Swab from urethra, cervis (throat, rectum) or urine (NAAT) & culture
Treatment o Ceftriaxone (Intramuscular Injection) & azithromycin
Presentation, diagnosis and treatment of herpes
Clinical Presentation of Primary Genital Herpes
o Extensive, painful genital ulceration, dysuria, inguinal lymphadenopathy, fever
Clinical Presentation of Recurrent Genital Herpes
o Asymptomatic to Moderate
Diagnosis: Smear and swab (then PCR) of vesicle fluid and/or ulcer base
Treatment
o Aciclovir
Presentation, management & treatment of genital warts
Clinical Presentation
o Cutaneous, mucosal and anogenital (anus and genital) warts
o Benign, painless, verrucous epithelial or mucosal outgrowths
o Penis, vulva, vagina, urethra, cervix, perianal skin
Diagnosis
o Clinical, biopsy and genome analysis, hybrid capture
Treatment
o None – frequent spontaneous resolution
o Topical podophyllin, cryotherapy, intralesional interferon